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ABSTRACT 
Diet-induced obesity (DIO) has been shown to increase DNA methyltransferase (DNMT) 
expression and DNMT binding at obesity-associated genes. Natural compounds have the 
potential to reverse obesity-associated gene expression via the regulation of DNA methylation. 
The objective of this study was to determine the effect of the bioactive compounds of flaxseed on 
DNMT and obesity-associated gene expression. Sixty C57BL/6J male mice were randomly 
assigned into one of the following diet groups and fed for eight weeks: 45% kcal fat; 45% kcal 
fat, 10% whole flaxseed; 45% kcal fat, 6% defatted flaxseed; 45% kcal fat, 4% flaxseed oil; and 
16% kcal fat. DNMT1, DNMT3a, DNMT3b, leptin, and peroxisome proliferator-activated 
receptor (PPAR)-α expression levels in muscle and adipose tissues were determined by real-time 
PCR.  
The results indicate that bioactive compounds of flaxseed affect selected gene expression. 
Further research is needed to identify the specific mechanisms regulating leptin or PPAR-α 
expression during DIO development. 
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LIST OF DEFINITIONS 
Flaxseed oil………………………..The fat component derived from flaxseed; rich in omega-3 
fatty acid, alpha-linolenic acid (ALA) (Baranowski et al., 
2012). 
Defatted flaxseed………………….The portion of flaxseed when the fat is removed. It contains 
lignans with antioxidant properties, including 
secoisolariciresinol diglucoside (SDG) (Wang et al., 2010). 
This also contains protein (Oomah & Mazza, 1993) and fiber 
(Qian, Cui, Wu, & Goff, 2012). 
DNA methylation………………… The addition of methyl groups to the promoter region of 
genes. Contributes to the expression or silencing of genes 
(Lavebratt, Almgren, & Ekström, 2012).  
DNA methyltransferases (DNMTs)..The enzymes involved in DNA methylation. These include 
DNMT1, DMNT3a, and DNMT3b which are responsible for 
de novo methylation and play a role in gene expression 
(Lavebratt, Almgren, & Ekström, 2012). 
Epigenetics……………………….. Heritable non-genetic cellular memory resulting in 
differently expressed physical characteristics or phenotypes 
without actual changes to DNA sequence (Riddihough, & 
Zahn, 2010). Epigenetic mechanisms include DNA 
methylation, histone modifications, and chromatin 
remodeling (Choi & Friso, 2010). 
Phenotype……………………….. A product of the interaction between inherited allelic variation 
and environmental factors, which results in an observable 
characteristic and is accompanied by alterations in gene 
expression (Koza et al., 2006). 
Gene expression…………..............Messenger ribonucleic acid (mRNA) is reverse transcribed 
into complimentary deoxyribonucleic acid (cDNA) and used 
as a template in polymerase chain reaction (PCR) in which 
amplification is detected as fluorescence. The fluorescence is 
then quantified as gene expression (Bio-rad, 2015). Gene 
expression is presented as relative gene expression by fold 
change in expression, which is determined by comparison to 
an internal control gene (Schmitten & Livak, 2008). 
Upregulation………………………Increased expression of a gene resulting from increased 
transcription (Chiba et al., 2004). 
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CHAPTER 1. INTRODUCTION 
In the past decade, the prevalence of obesity has increased dramatically in the United 
States. This is a serious and costly issue. More than one-third of the adult population and 17% of 
children are obese (Centers for Disease Control and Prevention, 2012). In 2010, 69.2% of adults 
20 years of age or older were considered overweight or obese. Obesity greatly increases the 
likelihood of developing many chronic diseases including heart disease, Type 2 diabetes, certain 
types of cancers, and stroke. In 2008, the estimated cost of obesity in the United States was 147 
billion dollars (Centers for Disease Control and Prevention, 2012). Identifying the factors 
involved in the development and regulation of obesity may facilitate the development of a 
solution. 
There has been speculation as to the cause of this dramatic increase in obesity. Nutrition 
has been a primary focus. Many have attempted to identify the role of diet in increased weight 
gain, and how to manipulate it to promote weight loss. 
Whole flaxseed has been recognized as a potential aid in weight loss because of its rich 
source of health-promoting compounds such as omega-3 fatty acid and the antioxidant lignan, 
secoisolariciresinol diglucoside (SDG). The flaxseed hull contains the greatest amount (11.7–
24.1g SDG/kg defatted ﬂaxseed) of SDG (Zhang & Xu, 2007).Therefore, defatted flaxseed has 
been used in the studies to determine the activity of SDG in the body (Wang et al., 2010). SDG 
has shown beneficial effects in high-fat diet-fed obese mice in relation to bodyweight (Park & 
Velasquez, 2012; Fukumitsu et al., 2008). Flaxseed oil has been studied for its effect on health 
because of its high percentage of omega-3 fatty acid. Flaxseeds contain about 36-40% total fat, 
in which omega-3 fatty acid account for about 53.2% of total fat (Popa et al., 2012). Flaxseed oil 
reduced the size of adipocytes, resulting in better function of fat cells by reducing harmful 
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inflammatory markers such as monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis 
factor-α (TNF-α) within adipose cells (Baranowski et al., 2012).  
Many other elements have been identified as factors in obesity development, including 
genetics. Epigenetics is a branch of genetics which shows promise in regards to obesity 
prevention and treatment. The methylation of deoxyribonucleic acids (DNAs) can dictate 
whether the gene is expressed or silenced. Epigenetic regulations in gene expression by dietary 
elements have been observed in breast cancer. Dietary compounds, such as epigallocatechin 
gallate (EGCG), genistein, witheferin A, curcumin, resveratrol, and guggulsterone, are effective 
in altering the methylation pattern of DNAs involved in tumor development by down-regulation 
of deoxyribonucleic acid methyltransferases (DNMTs) (Mirza et al., 2013). This same effect has 
not yet been observed in regards to flaxseed consumption, but could potentially regulate the 
expression of genes with a recognized role in obesity. 
Both leptin and peroxisome proliferator-activated receptor alpha (PPAR-α) have a known 
role in obesity. PPAR-α increases energy expenditure (Lefebvre, Chinetti, Fruchart, & Staels, 
2006), while leptin decreases energy intake (Mahan et al., 2012). If the expression of these genes 
could be influenced by diet, this mechanism could play a prospective role in obesity prevention.  
Statement of the Problem 
Obesity has become a problem in the United States. Introducing foods with properties 
that can alter the expression of genes involved in the development of obesity into the diet is a 
potential tool. This has been achieved in other conditions through epigenetic modulation by 
DNA methylation, but has not been fully established in obesity. 
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Purpose of the Study 
 The purpose of this study was to identify a relationship between the different health-
promoting compounds of flaxseed, SDG and omega-3 fatty acid, and the expression of DNMTs, 
leptin, and PPAR-α in an obese mouse model. A second objective was to establish a relationship 
between expression of DNMTs relative to the expression of genes with a known role in obesity, 
such as leptin and PPAR-α. Finally, a correlation between gene expression and body weight in 
male C57BL/6J mice was also determined.  
Research Questions 
The followings are research questions this study aimed to answer: 
1. Does dietary intervention affect the mRNA expression of DNMTs? 
2. Does dietary intervention affect the mRNA expression of leptin or PPAR-α? 
3. Does DNMT expression correlate with expression of leptin or PPAR-α? 
4. Does leptin or PPAR-α expression correlate with bodyweight?  
Hypothesis  
The hypothesis for this study was that flaxseed supplementation would decrease 
expression of DNMTs, increase expression of leptin or PPAR-α, and decrease body weight in an 
obese animal model. 
 
 
 
Figure 1. Schematic Representation of Hypothesis  
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Limitations 
Possible limitations to this study involving the animals include the short duration of the 
feeding intervention, which may not have allowed the mice to gain sufficient weight. Studies 
with feeding interventions extended beyond eight weeks have shown significantly more weight 
gain in C57BL/6J mice (Lin, Thomas, Storlien, & Huang, 2000). This study was performed 
using an animal model and may not be generalizable to humans in regards to regulatory 
mechanisms involved in obesity and obesity reduction, which are different between species. This 
experiment was carried out in a controlled setting and may not accurately represent the events 
occurring in a natural environment.  
Possible limitations to methodology include fluctuations and variations in gene 
expression detected by RT-qPCR, which may be influenced by operator variability (Bustin & 
Nolan, 2004). Another limitation to methodology was not including western blotting to confirm 
proteins identified by RT-qPCR.  
Delimitations 
To minimize limitations pertaining to the animals, all persons involved in this project 
were trained and qualified to perform all duties involving the mice. All necessary measures were 
taken to keep the animals healthy throughout the course of the study, and in the event of an issue 
the veterinarian was notified. A sample size of 12 mice in each group to achieve a power of 0.8 
and an alpha error rate equal to 5% was used to achieve statistical significance. The diets 
represent a high-fat diet with 45% of calories coming from fat as well as a low-fat diet that has 
16.4% of calories from fat to ensure diet-induced obesity by the mice.  
To minimize errors related to the methodology, each gene target was run in duplicates to 
ensure results are directly related to difference in gene expression. A negative, water, and 
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endogenous control, 18S rRNA, was used during RT-qPCR analysis to minimize the effect of 
outside factors.  
Assumptions 
The following are assumptions in this research: 
1. The mice will develop diet-induced obesity.  
2. The mice consuming the high-fat diet supplemented with defatted flaxseed will show 
lower expression of DNMTs and higher expression of leptin and PPAR-α, and will have a 
lower body weight gain than the high-fat control group, as well as the mice fed with 
whole flaxseed or flaxseed oil supplemented diet. 
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CHAPTER 2. REVIEW OF LITERATURE 
Obesity 
The World Health Organization (WHO) defines obesity as a body mass index (BMI) of 
30kg/m2 or greater. Increased accumulation of fat mass in the body results when a person takes 
in more energy than is expended for an extended period of time (Centers for Disease Control and 
Prevention, 2012). Obesity is characterized by inflammation and adipocyte hypertrophy. The 
combination of these two can lead to the accumulation of harmful substances into adipose tissue 
and dysfunction of the cells (Baranowski et al., 2012). Obesity greatly increases the likelihood of 
developing many chronic diseases including heart disease, Type 2 diabetes, certain types of 
cancers, and stroke (Centers for Disease Control and Prevention, 2012). A study of black and 
white men and women in the U.S. found that increased body mass is associated with higher risk 
of mortality across age groups, and is increasing for younger age groups in particular (Masters et 
al., 2013). These results indicate that obesity-related mortality will only continue to grow. 
The National Health and Nutrition Examination Survey 2009-2010 reported that more 
than one-third (35.7%) of U.S. adults and 17% of children are classified as obese. In the United 
States, the prevalence of obesity increased greatly from 1990 to 2010. In 2010, as many as 13 
states classified 30% or more of its population as obese (Centers for Disease Control and 
Prevention, 2012). The reason for this dramatic increase in obesity is widely investigated. 
Obesity is believed to be a combination of environment, genetics, decreased physical activity, 
and increased consumption of food and energy dense foods (Centers for Disease Control and 
Prevention, 2012). One of the many factors currently being researched as a contributor to obesity 
is epigenetics. Conversely, epigenetics may also be protective factor against the development of 
obesity. 
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Epigenetics 
 Epigenetics is a type of non-genetic cellular memory that can be affected by 
environmental factors. Epigenetic alterations affect gene expression without making changes to 
the deoxyribonucleic acid (DNA) sequence, and result in an alternative phenotype or observable 
characteristics. Epigenetic modifications are alterations to DNA that can be reversed, passed 
from one generation to the next, and maintained throughout replication and transcription 
(Riddihough & Zahn, 2010). Epigenetic mechanisms include DNA methylation, histone 
modification, and chromatin remodeling (Choi & Friso, 2010).  
 The epigenome refers to the changes in gene expression resulting from environmental 
factors (Genetics and Social Science, 2015). There are several ways in which the environment 
can affect the epigenome. For example, exercise may cause alternative gene expression in the 
brain as has been observed in mice (Able & Rissman, 2013). Diet also has been hypothesized to 
lead to abnormal gene expression resulting in cancer (Jaenisch & Bird, 2003). These are just a 
couple of studies that support the theory that environmental exposures can modify gene 
expression due to epigenetic modifications. 
 With the increased prevalence of obesity in recent years, epigenetic regulation of weight 
gain has attracted considerable attention. It is known that genes are differently expressed in the 
obese state when compared to a lean control (Baranova et al., 2005; Koza et al., 2006; Moraes et 
al., 2003), which makes obesity a plausible target for epigenetic modification. Diet and nutrition 
are environmental factors that have been researched as a potential target for this type of 
mechanism, which will be reviewed in the following section. 
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Nutrition 
There is evidence to suggest that changes in the diet may have an effect on weight gain 
through epigenetic mechanisms. Specifically, diet composition and/or dietary compounds are 
proposed to mediate this effect. This has been observed in studies where differences in diet 
between groups lead to differential gene expression and ultimately improvement in obesity-
related indicators.  
 Miller et al. (2008) used a diet-induced obesity (DIO) mouse model to identify the 
changes in gene expression due to diet composition, as well as gene expression following weight 
loss after DIO. There were four diet groups including a low-fat (10% fat), high-fat (60% fat), 
high-carbohydrate with low-fat liquid formula (1674kj/L, 10% fat), and a high-fat energy 
restricted diet, which was pair fed with the high-carbohydrate with low-fat liquid formula group. 
The energy-restricted group was given a quantity of food to match the bodyweight of the high-
carbohydrate group as determined in a pilot study. After 13 weeks of experimental diet feeding, 
half of the high-fat group was switched to a low-fat diet for weight loss, while the other half 
continued the high-fat diet. When analyzing gene expression in the adipose tissue of the mice, 
the high-carbohydrate and the high-fat restricted group showed global differences in gene 
expression patterns, regardless of body weight. Due to mice of the same body weight having 
different gene expression patterns, the authors concluded that diet composition was responsible 
for changes in gene expression, and the possibility of epigenetic involvement. The high-fat, low-
fat, and weight reduction group also showed three distinguishable gene expression patterns, 
further indicating the effects of diet on gene expression. Altered gene expression was maintained 
in the weight reduction group after maintained weight loss following DIO, which the authors 
concluded may also be due to epigenetic involvement (Miller, Becker, Prabhu, & Cooke, 2008). 
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Although this study doesn’t explain the role of altered gene expression in development or 
reduction of obesity, it provides evidence that diet is an environmental factor that can alter gene 
expression. 
As mentioned previously, reversibility of gene expression is a key component of 
epigenetic mechanisms. In order for diet to be an epigenetic regulator, it must produce changes 
in gene expression that are reversible. To study this, Wistar rats were fed either a standard diet 
(10.3% fat) or a high-fat-sucrose (HFS) diet (45% fat) in which half of the rats from the HFS diet 
were switched to the standard diet after 10 weeks. At the end of 20 weeks, the rats were 
sacrificed and the retroperitoneal adipocytes were analyzed for changes in gene expression. The 
results indicated that being switched to the standard diet following a HFS diet induced epigenetic 
changes including alterations in methylation of genes involved in obesity, specifically the 
promoter regions of leptin, and fatty acid synthase (Fasn). Examination of the promoter regions 
showed both hyper- (CpG sites 6-7 and 29-30) and hypomethylatoin (CpG site 15) of leptin and 
hypomethylation of Fasn (CpG site 1 and 5). These results denote that diet can reversibly modify 
gene expression (Uriarte, Paternain, Milagro, Martinez, & Campion, 2013).  
 Researches have shown that supplementation of certain compounds is protective against 
weight gain regardless of diet. For example, Pichiah et al. (2012) examined the effects of 
seabuckthorn extract (Hippophae rhamnoides L) on obesity through regulation of food intake 
and gene expression utilizing a male C57BL/6J obesity-prone mouse model. Eight mice were 
assigned to one of four dietary treatments including a normal diet, a high-fat diet control group, a 
high-fat diet supplemented with 500 mg/kg body weight seabuckthorn ethanolic extract, or a 
high-fat diet supplemented with 1000 mg/kg body weight seabuckthorn ethanolic extract for 13 
weeks. At the end of the study, the mice supplemented with seabuckthorn extract did not gain 
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significant weight compared to the normal diet group. Although serum leptin was higher in all 3 
high-fat diets, it was reduced in the seabuckthorn extract supplemented diets compared to the 
high-fat diet alone. The liver tissue was analyzed for expression of genes with a known role in 
obesity including PPAR-α, PPAR-γ, and carnitine palmitoyltransferase-1(CPT-1). PPAR-γ 
expression was higher in the group supplemented with 1000 mg/kg seabuckthorn compared to all 
other groups. PPAR-α and CPT-1 expression was significantly higher in the 1000 mg/kg 
seabuckthron group compared to the other high-fat groups. These results indicated 
supplementation of a dietary compound was successful in preventing obesity and was 
accompanied by an altered expression of genes when consuming a high-fat diet (Pichiah, Moon, 
Park, Moon, & Cha, 2012). It is of interest whether or not similar results can be observed 
through epigenetic regulation. 
 Sohair et al. (2015) performed a similar study focusing on non-alcoholic fatty liver 
disease in which mice were fed a standard diet or high-fat, high-sucrose diet (HFHS) and 
supplemented with one of three dietary compounds: quercetin, berberine, or o-coumaric acid. 
They found that the HFHS diet led to reduced PPAR-γ expression compared to the rats fed a 
standard diet. However, when consuming a HFHS diet supplemented with berberine, PPAR-γ 
expression was significantly upregulated compared to the HFHS diet alone. This is significant 
because of the function of PPAR-γ in metabolic disorders/obesity which is associated with 
improved insulin resistance and glucose tolerance (Ragab, Elghaffar, El-Metwally, Badr, 
Mahmound, & Omar, 2015).  
Because obesity has been shown to be accompanied by changes in gene expression and 
diet is associated with reversible changes in gene expression, diet composition is a likely target 
for studying epigenetic modification. As discussed previously, specific compounds have been 
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identified that lead to less weight gain and/or improvement in obesity-related indicators despite 
consumption of a high-fat diet. Specific to the current study it is of interest whether or not the 
health promoting compounds present in flaxseed are capable of producing anti-obesity effects via 
epigenetic mechanisms.   
Flaxseed 
Flaxseed has attracted attention for its potential health benefits, which include a positive 
impact on weight loss. According to the United States Department of Agriculture (USDA), 
flaxseed contains fiber and has been studied for its possible role in cholesterol reduction (Nandi 
& Ghosh, 2015). Flaxseed is about 27% fiber and 18% protein per 100 grams (USDA, 2016). For 
the purpose of this study we focused on health benefits of flaxseed due to its omega-3 fatty acid 
(Baranowski et al., 2012) and antioxidant lignan content (Park & Velasquez, 2012).  In addition 
to whole flaxseed, individual components of flaxseed have been shown to influence body weight. 
Flaxseed contains omega-3 fatty acid in the form of α-linolenic acid (ALA) (Baranowski 
et al., 2012). Flaxseed oil has been observed to be beneficial in the obese state by improving 
adipocyte function without reducing body weight by reducing adipocyte size and decreasing the 
amount of inflammatory markers such as MCP-1 and tumor necrosis factor-α (TNF-α) in adipose 
tissue (Baranowski et al., 2012). Additionally, supplementation with flaxseed oil has also 
provided protective mechanisms that coincide with consuming a diet high in fats or 
carbohydrates by preventing weight gain, decreasing blood glucose levels, decreasing blood 
lipids and improving lipid profile (El-Shobaki, Mohamed, Abd-El-Azeem, & Hegazy, 2013). 
Although it is clear that flaxseed oil is beneficial in obesity, it is significant to know if it can 
influence gene expression to combat obesity.  
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Alpha-linolenic acid (ALA) from flaxseed has the potential to be involved in epigenetic 
regulation. Pregnant mice supplemented with flaxseed oil had significantly increased 
methylation on intron 1 of the fatty acid desaturase 2 (FADS2) gene compared to a control group 
that received soybean oil as the fat source. This was also observed in the promoter region of 
FADS2 in the flaxseed oil supplemented group compared to the control group, but this was only 
significant when the mice were first provided a diet that was deficient in ALA prior to pregnancy 
(Niculescu, Lupu, & Craciunescu, 2012). Due to flaxseed oil supplementation showing positive 
effects in obesity and having epigenetic potential, flaxseed oil is a plausible topic of study in 
epigenetic regulation of weight gain.  
Secoisolariciresinol diglucoside (SDG) is the bioactive compound in flaxseed exhibiting 
antioxidant properties (Park & Velasquez, 2012). To study its effects in obesity, Park and 
Velasquez (2012) fed rats a high-fat/high-fructose diet supplemented with 0.02% SDG lignan-
enriched flaxseed powder, which was determined to provide about 1.5 mg SDG lignan per day 
after calculating average daily food intake of the rats. Compared to rats fed a standard diet, those 
supplemented with SDG showed significantly less weight gain, visceral fat accumulation, plasma 
leptin concentration, and an improvement in lipid profile and systolic blood pressure. These 
results indicate when consuming a high-fat/high-fructose diet, supplementation with SDG can 
ameliorate obesity while exhibiting positive effects on blood pressure and lipid profiles (Park & 
Valasquez, 2012).  
Tominaga et al. (2012) investigated the effects of a synthetic pure form of 
secoisolariciresinol, (-)-secoisolariciresinol ((-)-SECO),which is the metabolite of SDG.  The 
study was carried out in a diet-induced obesity mouse model. The authors hypothesized that (-)-
SECO would inhibit weight gain in DIO. Mice were fed either a high-fat or standard diet. Oral 
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administration of (-)-SECO was given at 0, 0.058, 0.58, and 5.8 mg/kg body weight. Body 
weight was reduced at all three doses of (-)-SECO, but was only statistically significant at 5.8 
mg/kg body weight, which was reduced by 31% compared to a high-fat control group. This 
result was independent of food intake. In the liver tissue of the (-)-SECO treated mice, decreased 
expression of fatty acid synthase (Fasn) and sterol regulatory element-binding protein (SREBP)-
1c,was observed.  This finding is significant because decreased expression of these genes 
indicate decreased fat synthesis (Tominaga et al., 2012). Decreased body weight gain, and 
reduced expression of obesity associated genes with (-)-SECO supplementation may indicate the 
ability of flaxseed lignan to prevent weight gain in DIO by regulation of gene expression.  
 Both the antioxidant and omega-3 fatty acid components of flaxseed have been shown to 
improve negative health indicators in obesity such as adipocyte function, inflammatory makers 
(Baranowski et al., 2012), blood pressure, and blood lipid profiles (Park & Velasquez, 2012). 
Secoisolariciresinol diglucoside and ALA also appear to potentially be influenced by epigenetic 
regulation. When discussing epigenetic regulation of gene expression, it is important to 
understand the mechanism by which substances work. There is evidence that nutritional 
components may affect the way DNA is transcribed, resulting in more or less weight gain.  
DNA Methylation 
 As discussed earlier, DNA methylation is an epigenetic mechanism. Methylation is the 
addition of methyl groups to the DNA structure most often occurring at C-phosphate-G (CpG) 
dinucleotides. The group of enzymes responsible for altering the way DNA is methylated are 
called DNA methyltransferases (DNMTs). Three of interest in gene expression include DNMT1, 
DNMT3a, and DNMT3b. Deoxyribonucleic acid methyltranferase1 assures identical methylation 
patterns of genes in each cell division, and DNMT3a and DNMT3b are responsible for the 
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addition of methyl groups to genes (Lavebratt, Almgren, & Ekstrom, 2012). The role of other 
DNMTs such as DNMT2, is not as well understood (Schaefer et al., 2010). Addition of methyl 
groups to DNA prevents transcription of the gene due to limited availability for transcription 
factors (Shen et al., 2014). Conversely, less methylation of genes leads to increased expression of 
the gene. Deoxyribonucleic acid methylation has been found to repress the expression of tumor 
suppressor genes by hypermethylation (Rhee et al., 2002).  We aim to determine whether a 
similar mechanism can be observed with the addition of health-promoting compounds to the diet.  
Fang et al. (2003) have shown that EGCG a polyphenol found in green tea inhibits DNA 
methyltransferase activity and consequently, reactivates genes involved in tumor development 
(Fang et al., 2003). This is significant because it shows that consumption of a dietary compound, 
and more specifically a polyphenol, can lead to increased expression of genes by preventing 
DNMTs from adding methyl groups to genes. Flaxseed also contains polyphenols making it an 
appealing target for similar research. 
 Moleres et al. (2013) examined the DNA methylation response to weight loss of obese 
adolescents. Subjects were obese adolescents who participated in a 10-week intervention for 
weight loss. They were divided into two groups based on weight loss response; high and low 
responders. High responders lost greater than 1.1 BMI-standard deviation score (BMI-SDS) 
(n=12) and low responders lost less than 0.4 BMI-SDS (n=12). A methylation score of 27,578 
CpG sites of 14,495 genes was calculated comparing baseline methylation of DNA, obtained 
through venous blood, to methylation after the intervention. Those with the highest methylation 
score had a greater BMI-SDS decrease than those with a lower methylation score. To confirm 
results, they analyzed seven CpG sites correlated to genes AQP9, DUSP22, HIPK3, TNNI3, 
TNNT1, F12, and PTPRG by matrix assisted laser desorption/ionization – time of flight 
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(MALDI-TOF) (n=107). This approach also revealed significant changes in DNA methylation 
between the two groups in five of the regions. AQP9 is involved in lipogenesis and is associated 
with increased weight gain. Therefore it is likely the that increased methylation score of the 
subjects who better responded to weight loss had reduced expression of this gene, resulting in 
more weight loss (Moleres et al., 2013). This work is evidence that genes involved in weight 
regulation are potential targets for the study of epigenetic modification by DNA methylation.  
To examine the mechanism responsible for changing the methylation patterns and the 
resulting expression of a gene, Milagro et al. (2009) studied the methylation pattern of gene 
promoters. They used male Wistar rats to observe the effects of a high-fat diet on the methylation 
pattern of the leptin promoter obtained from retroperitoneal adipocytes. They were able to 
identify a region on the promoter that showed increased methylation in the animals fed the high-
fat diet, which correlated with lower leptin levels in the blood. This is significant because it 
suggests that the methylation pattern of the promoter region may regulate the expression of 
leptin, a gene involved in energy metabolism, as well as the involvement of diet in epigenetic 
regulation of leptin (Milagro et al., 2009).  
Fujiki et al. (2009) examined the relationship between the methylation pattern and 
expression of a gene involved in adipocyte regulation, PPAR-γ. They observed hypermethylation 
on the promoter of PPAR-γ in pre-adipocytes. During differentiation, it was de-methylated 
leading to increased mRNA expression. They also treated the cells with a DNA methylation 
inhibitor, which resulted in increased PPAR-γ expression in a dose dependent manner. They 
observed increased methylation and reduced expression of PPAR-γ in visceral adipose tissue of 
diabetic mice compared to wild type mice. The authors concluded that PPAR-γ is regulated by 
methylation of the promoter region and that DNA methylation and metabolic syndrome may be 
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related (Fujiki, Kano, Shiota, & Murata, 2009). This is evidence that increased methylation leads 
to gene silencing and this can occur in genes with a role in energy regulation. In our study, we 
aimed to identify the role of other genes involved in the development of obesity and subsequent 
regulation by DNA methylation. 
Jacobsen et al. (2012) studied the effects of short-term high-fat overfeeding (HFO) on 
DNA methylation in human skeletal muscles. The participants consumed a control diet (35% fat, 
50% carbohydrates, 15% protein) or a HFO diet (60% fat, 32.5% carbohydrates, 7.5% protein) 
providing 50% more calories than the control diet for five days followed by a washout period of 
six to eight weeks and then consumed the other diet. In the group that consumed the control diet 
first, they observed that following the HFO diet, DNA methylation was increased in 83% of CpG 
sites, most of which (98%) were hypomethylated in the control diet. They also observed a 
change in methylation of 24 genes associated with type 2 diabetes, such as cyclin-dependent 
kinase inhibitor 2A and 2B (CDKN), solute carrier family 30 (zinc transporter) member 8 
(SLC30A8), and PPAR-γ, following the HFO diet. In the group that consumed the HFO diet 
first, they did not see a significant change in methylation. However, they did observe a trend 
towards reversibility, showing non-significant changes in methylation of genes. This was 
particularly observed in the genes that were most affected by the HFO diet in the participants in 
the control diet first group. They did not observe significant changes in gene expression overall 
in either group, although they did observe a trend towards increased expression of DNMT3a and 
DNMT1 (p=0.08 and p=0.10, respectively). The experimental diets were provided over a short 
duration, but the changes in DNA methylation and trend towards reversibility by the HFO 
provide evidence that the methylation pattern may influence gene expression during long term 
interventions (Jacobsen et al., 2012). This provides further evidence that diet affects the 
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methylation pattern of genes; however, the relationship between methylation and gene 
expression must be determined to establish if an epigenetic mechanism is involved. It also shows 
that muscle is a potential tissue to study in regards to epigenetic regulation.  
Elango et al. (2009) studied the role of DNA methylation in Apis mellifera, otherwise 
known as the western honeybee. They observed that genes with low-CpG content were involved 
in basic biological processes whereas genes with high-CpG content were involved in 
developmental processes. The low-CpG content is indicative of DNA methylation due to 
deletion of CG rich regions over time. However, the authors hypothesized that genes with high-
CpG content or genes involved in developmental processes are more subject to epigenetic 
regulation (Elango, Hunt, Goodisman, & Yi, 2009). Therefore, it is possible that genes with a 
high content of CpG rich regions, especially in the promoter region, or genes involved in 
developmental processes are likely targets for epigenetic regulation by DNA methylation.  
It is clear that diet can act as an environmental factor to epigenetically regulate gene 
expression. In our study we chose genes known to be involved in obesity development.   
Obese Gene Expression 
 Both peroxisome proliferator-activated receptors and leptin are involved in obesity 
development, and are therefore favorable targets for studying regulation of weight gain. 
Peroxisome Proliferator-Activated Receptor Alpha 
Peroxisome proliferator-activated receptors (PPARs) are transcription factors that 
regulate the activity of proteins involved in energy metabolism. Peroxisome proliferator-
activated receptor alpha is one of the three isoforms, and is highly expressed in the liver and 
skeletal muscle, in addition to other tissues. In the liver, it induces the expression of 
enzymes/proteins that enable fatty acid oxidation such as fatty acid transport proteins, long-chain 
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acyl-CoA synthetase, and acyl-CoA oxidase. In the skeletal muscle in particular, PPAR-α 
induces expression and regulates activity of pyruvate dehydrogenase kinase 4 (PDK4) involved 
in energy metabolism (Ferre, 2004).  
Guerre-Millo et al. (2000) examined the effects of a known PPAR-α activator, 
fenofibrate, on characteristics of metabolic syndrome. They observed that C57BL/6 mice fed a 
high-fat diet supplemented with fenofibrate (0.05%) gained less perirenal and epididymal fat 
than mice fed the same diet without supplementation, regardless of intake (Guerre-Millo et al., 
2000). This demonstrated the importance of PPAR-α in obesity regulation, and suggests that an 
increase in this gene may help prevent weight gain due to a high-fat diet.  
A similar study was conducted with male Wistar rats. A different PPAR-α agonist, 
WY14643, was used. Wistar rats fed a high-fat diet (59% fat, 21% protein, 20% carbohydrate), 
supplemented with WY14643(3 mg/kg body weight/day) had significantly less muscle and liver 
triglyceride accumulation and less visceral fat weight gain than rats fed the same diet without 
supplementation (Ye et al., 2001). This also shows the importance of PPAR-α in regards to 
weight regulation, and this mechanism is carried out in muscle tissue.  
As discussed earlier, when a dietary element with health-promoting properties such as 
seabuckthorn is added to the diet, the expression of PPAR-α increased (Pichiah et al., 2012). The 
results of the study suggest the involvement of diet in the regulation of PPAR-α expression. It is 
plausible that another dietary compound, such as flaxseed, may be able to produce a similar 
effect. 
 Lee et al. (2012), studied the effects of Adenophora triphylla (A TREE) on obesity and 
PPAR-α expression in a DIO mouse model. A TREE was used because it has antioxidant 
activity. Mice were fed one of five diets including a normal control, a high-fat control, a high-fat 
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diet supplemented with 0.5% catechin, or a high-fat diet supplemented with 0.5% or 1% A 
TREE. Catechin was used as a control because it also acts as an antioxidant. Supplementation 
with catechin and A TREE was provided after five weeks of feeding a high-fat diet alone. 
Feeding was continued for an additional five weeks, resulting in a 10-week feeding time. They 
found that A TREE was not as strong of an antioxidant as catechin based on its electron donating 
capacity. However, A TREE caused a significant reduction in xanthine oxidase (XO) and 
thiobarbituric acid reactive substances (TBARS) and an increase in catalase (CAT) and 
superoxide dismutase (SOD) activity in vivo compared to the high-fat diet alone, indicating 
antioxidant capabilities. Following supplementation of A TREE and catechin, adipocyte size was 
reduced by 28.4% and 42.8% respectively, compared to the high-fat control group. In the A 
TREE groups, body weight gain was significantly less than the high-fat control group. In the 
liver tissue, PPAR-α expression was significantly increased in the A TREE group in a dose 
dependent manner compared to the high-fat control group. The authors concluded that A TREE 
produces anti-obesity effects and acts as an antioxidant (Lee, Lee, Lee, Kim, & Kim, 2013). This 
indicates that a compound with antioxidant capabilities correlates with both decreased body 
weight and increased expression of PPAR-α. It is plausible that other compounds with 
antioxidant capabilities, such as SDG, may have a similar effect on PPAR-α expression and 
weight gain in conjunction with a high-fat diet. However, it remains to be determined if a dietary 
compound such as flaxseed that also has antioxidant properties can alter PPAR-α expression by 
DNA methylation.  
Leptin  
Leptin is another gene of interest because of its role in obesity. Leptin is a hormone that 
acts on the central nervous system to regulate energy intake and expenditure (Meiera & 
20 
 
Gressner, 2004). However, leptin administration results in different effects on intake in obese vs. 
non-obese animals. Using an animal model, Moraes et al. (2003) studied leptin in diet-induced 
obesity. Decreased food intake and fat stores were seen in lean control mice given leptin; 
although, it was not seen in the obese mice. The large amounts of leptin circulating in the plasma 
of the obese mice, without coinciding weight loss, indicated leptin resistance (Moraes et al., 
2003).This is an example of leptin resistance, in which leptin no longer exhibits its function due 
to defects in the leptin receptor and signaling pathway (Crujeiras et al., 2015). Therefore, 
because increased leptin expression doesn’t necessarily indicate increased leptin action due to the 
development of leptin resistance, increased leptin expression must not be considered without 
changes in body weight. 
El-Haschimi et al. (2014) identified two possible mechanisms responsible for leptin 
resistance in an animal model of diet-induced obesity mice. One was the inability of peripheral 
leptin to activate signal transducers and activators of transcription (STATs) in the hypothalamus, 
and the second was a defect of intracellular signaling of leptin (El-Haschimi, Pierroz, Hileman, 
Bjørbæk, & Flier, 2000). When targeting leptin as a treatment for obesity, the objective is to 
increase the expression of leptin in the cell rather than increase the amount of leptin circulating 
in the blood.  
In this study, we determined the impact of a high-fat diet on energy intake and leptin 
expression and correlation with weight gain. Milagro et al. (2009) studied the effect of a high-fat 
diet on the methylation pattern of the leptin promoter. They used male Wistar rats and assigned 
them to either a standard diet (16.6% protein, 73.1% carbohydrates, 10.3% fat) group or a 
cafeteria diet (9.3% protein, 31.5% carbohydrates, 59.2% fat) group and fed them for 11 weeks. 
The cafeteria diet group had increased circulating leptin levels and increased mRNA leptin levels 
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in retroperitoneal adipocytes. They also identified two CpG islands (-562 to -399 pb and -324 to 
-187 pb) that could be epigenetically regulated. One particular position, -443, was more highly 
methylated in the cafeteria diet group compared to the control. The extent of its methylation was 
correlated with lower circulating leptin and lower body weight in the cafeteria diet group. These 
results suggest that leptin can be epigenetically regulated by DNA methylation (Milagro et al., 
2009). Due to leptin expression being altered by diet and accompanied by altered promoter 
methylation, it is possible that leptin expression may be epigenetically regulated by diet. 
Boque et al. (2013) investigated the effects of apple polyphenols (AP) in conjunction 
with a high-fat sucrose (HFS) diet on weight regulation. Male Wistar rats were fed either a 
standard diet (20% protein, 67% carbohydrate, 13% fat), a HFS diet (20% protein, 35% 
carbohydrate, 45% fat), or a HFS diet supplemented with AP (0.70 g/kg rat). The rats were fed 
the HFS diet for 64 days and supplementation lasted for 56 days (Boque et al., 2012). When 
supplemented with AP, in the absence of differences in food intake, prevention of body weight 
and adiposity gain was observed in the rats. In epididymal adipocytes from the HFS diet group, 
leptin gene expression was up-regulated, but when supplemented with AP, leptin expression was 
observed to be the same as the rats on the standard diet. The increase in leptin expression is 
likely due to increased fat mass because adipose cells secrete leptin (Boque et al., 2013). The 
increased leptin expression with increased fat mass is counterintuitive due to the function of 
leptin in regulating energy intake and increasing energy expenditure. However, leptin resistance 
is developed in DIO (Moraes et al., 2003). Therefore, increased leptin expression does not mean 
increased leptin action and serum leptin needs to be measured to determine if leptin resistance is 
developed. The promoter region of leptin was also examined by Boque et al. (2013) to assess 
changes in the methylation pattern. It was found that CpG methylation (position -292 and -198) 
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increased in the HFS diet and was significantly reduced (position -198) with AP 
supplementation. There was a positive correlation between Lep_CpG22 methylation and leptin 
expression. The positive correlation observed was not expected because, typically, increased 
methylation leads to reduced expression; however, this could be due to where the methylation 
occurred (negative regulatory elements in the promoter). Leptin is a likely target for epigenetic 
modification through diet due to leptin expression correlating with the methylation pattern on the 
promoter region after supplementation, although the relationship is unclear (Boque et al., 2013).  
Fan et al. (2011) used a DIO mouse model to examine leptin promoter methylation. 
Although not statistically significant, they found that addition of n-3 FA to the diet indicated a 
trend towards reduced leptin promoter methylation. They also observed reduced leptin 
expression in the adipose tissue, decreased body weight, and decreased energy intake of the n-3 
FA diet groups than the n-3 FA deficient groups (Fan, Liu, Shen, Deckellbaum, & Qi, 2011). 
This provides evidence that n-3 FA supplementation in combination with a high-fat diet may 
prevent weight gain, and suggests a possible epigenetic involvement. Flaxseed also contains n-3 
FA; warranting further investigation regarding a possible connection between flaxseed 
consumption and epigenetic regulation of leptin expression.  
Epigenetics has become a field of great interest and shows promise as a target for obesity 
treatment. Flaxseed has shown many beneficial effects in the obese state and it remains to be 
seen if flaxseed modulates these effects by DNA methylation. More specifically if it can 
modulate the expression of PPAR-α and/or leptin.  
Summary 
Thus far literature shows a connection between diet composition and body weight. There 
is also evidence that the addition of certain compounds present in food can lead to less weight 
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gain despite consumption of a high-fat diet. Compounds present in food have been shown to 
influence gene expression leading to an alternatively expressed phenotype, especially in cancer 
studies. Current research is limited in regards to epigenetic regulation of weight gain. Flaxseed is 
an example of a food that has been shown to have beneficial effects on heath. Although, it is 
unclear what mechanism is responsible for producing these beneficial effects. In this study, we 
will examine the effects of flaxseed supplementation on body weight and obese gene expression. 
We will also look for the potential of epigenetic regulation by measuring DNA 
methyltransferases.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
CHAPTER 3. METHODS 
 Obesity has become a prominent issue in the United States. Researchers have targeted 
many of the contributing factors, one of which is epigenetics, in hopes of identifying a solution 
to the obesity epidemic. Mirza et al. (2013) identified epigenetic mechanisms capable of 
silencing genes involved in tumor cell development by the introduction of dietary compounds. A 
similar approach of adding flaxseed to the diet could be effective against obesity by influencing 
epigenetic mechanisms of gene regulation in adipose and muscle tissues. The purpose of this 
study was to identify the effects of different health-promoting compounds of flaxseed on the 
expression of deoxyribonucleic acid methyltransferases (DNMTs), leptin, and peroxisome 
proliferator-activated receptor alpha (PPAR-α). This study also aimed to investigate a 
relationship between the expression of DNMTs and the expression of genes with a known role in 
obesity, including leptin and PPAR-α. Finally, the correlation between gene expression of leptin, 
PPAR-α, and body weight was determined. This study was based on a parent study which was 
approved by the North Dakota State University (NDSU) Institutional Animal Care and Use 
Committee (IACUC #A13019).  
Research Design 
 A randomized control research design was used to compare gene expression of DMNTs, 
leptin, and PPAR-α by health-promoting components present in flaxseed added to the diet in an 
obese animal model. 
Flaxseed 
 Whole flaxseed was obtained from three different suppliers and pooled prior to milling. 
Milling was completed such that all particles passed a 30 mesh screen. The samples was defatted 
using a large soxhlet unit using hexane for 16 hours. After evaporation of the hexane the oil was 
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packaged in a bottle and stored frozen until needed for diet formulation. The defatted flaxseed 
from the soxhlet was air dried in a fume hood 12 hours prior and stored frozen until diet 
formulation.    
Animals and Diets 
 Five to six-week old male C57BL/6J mice (~20 g) were purchased from The Jackson 
Laboratory (Bar Harbor, Maine). The mice were selected because they are prone to diet-induced 
obesity when fed a high-fat diet (Tominaga et al., 2012). The animals were housed individually 
in plastic-bottom cages in the Animal Nutrition and Physiology Center at NDSU with a 
controlled 12-hour light: dark cycle. The room was kept at a temperature of 22-25°C and 
humidity of 42-55%. 
After two days of acclimation, the mice were randomly assigned into five treatment 
groups (n=12). Fresh food and water were provided daily and mice had access to food ad libitum. 
The diet was formulated by a commercial company (TestDiet, St. Louis, MO) in a pellet form. 
All groups were fed a high-fat diet, with the exception of group five, which was fed a low-fat 
diet. The high-fat diet consisted of 18% of calories from protein, 45% of calories from fat, and 
37% of calories from carbohydrates. The low-fat diet consisted of 19% of calories from protein, 
16% from fat, and 65% from carbohydrates (TestDiet, St. Louis, MO). Group one served as a 
high-fat control. Group two was supplemented with 10% whole flaxseed. Group three was 
supplemented with 6% defatted flaxseed. Group four was supplemented with 4% flaxseed oil. 
Group five was the low-fat control and pair-fed to group two. The amount of each component of 
flaxseed was formulated to reflect the amount present in whole flaxseed. The amount of food 
consumed by the mice in group two was measured daily and the same amount was weighed and 
fed to group five the following day. Animals were weighed weekly and food intake was also 
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measured weekly for monitoring of intake, with the exception of group two which was measured 
daily. After eight weeks of the experimental diet feeding, the mice were sacrificed with carbon 
dioxide (CO2) gas and then exsanguinated by anterior cardiac puncture. Skeletal muscle and 
adipose tissues were harvested, weighed, frozen in liquid nitrogen, and immediately stored at -
80°C.  
Oxidation of Mouse Food 
Peroxide values (PV) of the extracted oil was measured using AOCS Method Cd 8-53 
(1998) as modified by Crowe and White (2001). Extracted oil (0.5 g) was weighed into a 25 mL 
Erlenmeyer flask and 3 mL of acetic acid:chloroform (3:2 v/v) and 50 µL of potassium iodide 
was added and mixed for 1 min. Next, 3 mL of distilled water was dispensed into the mixture, 
followed by the addition of 300 µL of 1% starch indicator solution. The oil samples was then 
titrated using either 0.001 N sodium thiosulfate or 0.01 N sodium thiosulfate until a clear color is 
obtained. Peroxide values were calculated using the equation: peroxide value = [((S-B) * N * 
1000) / W], where S = volume of titrant for sample, B = volume of titrant for blank, N = 
normality of Na2S2O3 (meq/ml), 1000 = unit conversion (g/kg), and W = sample mass (g). The 
peroxide values of each treatment will be measured in duplicate.  
Gene Expression Measurement  
Ribonucleic Acid (RNA) Extraction 
Quantitative real-time polymerase chain reaction (RT-qPCR) was performed to quantify 
gene expression of DNMT1, DNMT3a, DNMT3b, leptin, and PPAR-α. Total ribonucleic acid 
(tRNA) was extracted from adipose and muscle tissues using TRI Reagent (Molecular Research 
Center, Cincinnati, OH). Five hundred microliters of TRI Reagent was added per 500 mg tissue 
for homogenization. Following homogenization of the tissues, 50 µl 1-bromo-3-chloropropane 
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(BCP) (Molecular Research Center, Cincinnati, OH) (1:10 ratio of BCP to TRI Reagent) was 
added and the samples were shaken vigorously for 30 seconds. They were then incubated at 
room temperature for two to three minutes and centrifuged at 12,000 x g for 15 minutes at 4°C 
(Allegra 21R centrifuge, Beckman Coulter). The supernatant containing the RNA was then be 
transferred into a new tube, 125 µl of isopropyl alcohol (IBI Scientific, Peosta, IA) and 125 µl 
high salt solution (0.8 M sodium citrate and 1.2 M NaCl) (Molecular Research Center, 
Cincinnati, OH) were added. The samples were centrifuged at 12,000 x g for 10 minutes at 4°C. 
Prior to centrifuging, the homogenized adipose tissue samples were held at room temperature for 
10 minutes. After centrifuging, the supernatant was removed and discarded. The remaining RNA 
pellet was washed twice with 500 µl 75% ethanol (Decon Labs, King of Prussia, PA) and then 
centrifuged at 12,000 x g for 5 minutes at 4°C. The RNA pellet was dissolved in 75 µl RNase 
free water and then incubated at 55-60°C for 10 minutes. The RNA pellet was dissolved in water 
stored at -80°C for subsequent RNA quantification. Following quantification, the RNA was 
diluted to 200 ng/µl. 
Reverse Transcription 
 A reverse transcription polymerase chain reaction into complimentary deoxyribonucleic 
acid (cDNA) was completed using 5X iScript Reverse Transcription Supermix (Bio-rad, 
Hercules, CA) on a PCR thermal cycler (Applied Biosystems 2720 thermal cycler, Applied 
Biosystems, Foster City, CA). Each reaction had a volume of 20 µl consisting of 4 µl 5X iScript 
Reverse Transcription Supermix, RNA template, and a variable volume of RNase free water, so 
that the amount of the RNA template was 1 ng/µl in a total volume of 20 µl per reaction.  
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Quantitative PCR 
Quantitative PCR was performed using SYBR Select Master Mix (Life Technologies, 
Carlsbad, CA) on a real-time PCR system (ABI 7500 Fast, Applied Biosystems, Foster City, CA) 
according to standard procedure. Total volume of each well was 10 µl, with 5 µl SYBR Select 
Master Mix, 1 µl each of forward and reverse primers (Table 1), and 3 µl of the cDNA template. 
Expression of DNMT1, DNMT3a, DNMT3b, leptin, and PPAR-α was s measured. 18sRNA 
expression was also measured and served as an internal control. The primer sequences were 
designed using Primer Express Software 2.0 (Applied Biosystems, Foster City, CA) and 
synthesized by Integrated DNA Technologies (IDT) (Coraville, IA), and are shown below (Table 
1). The fold change in expression of the DNMTs, leptin, and PPAR-α was calculated using 2- 
ΔΔCT method [(CT gene of interest – CT internal control) sample A – (CT gene of interest – CT 
internal control) sample B)] (Schmitten & Livak, 2008), where sample ‘A’ is the amplification 
detected by PCR from control or high-fat control/low-fat control and ‘B’ is the amplification 
detected by PCR from the experimental diet. 
Table 1. Primer Sequences Used for Quantitative PCR 
Gene Primer Combination 
DNMT1 
Forward 5'-TGT GGA TGA ACC CCA GAT GTT -3' 
Reverse 5'- GTG GAG TCG TAG ATG GAC AGT TTC T -3' 
DNMT3a 
Forward 5'- GGC TGG CAG GTT GGA AAA -3' 
Reverse 5'- CTG CAA TTA CCT TGG CTT TCT TC -3' 
DNMT3b 
Forward 5'- CCA AAA GGA GGC CCA TTA GAG -3' 
Reverse 5' CCC GTT GCA ATT CCA TCA A -3' 
Leptin 
Forward 5'- AGC CTG CCT TCC CAA AAT GT -3' 
Reverse 5'- CGG AGA TTC TCC AGG TCA TTG -3' 
PPAR-α 
Forward 5'- AGA TCG GCC TGG CCT TCT AA -3' 
Reverse 5'- CCC TCC TGC AAC TTC TCA ATG -3' 
18S rRNA 
Forward 5'- CGC CGC TAG AGG TGA AAT TCT -3' 
Reverse 5'- CTT TCG CTC TGG TCC GTC TT -3'  
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Statistical Analysis 
Statistical analysis was performed using SAS software (version 9.3, Cary, NC, USA). 
Differences in gene expression among diet groups were analyzed with a general linear model 
(GLM).  The relationship among gene expression levels and weight gain and obesity-associated 
gene expression was calculated by Pearson correlation coefficient. A Type I error rate (alpha 
level) of 0.05 was used to assess significance.  Peroxide value data was analyzed by analysis of 
variance (ANOVA) with a p-value of 0.05.  
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CHAPTER 4. RESULTS 
Food Intake 
 Food intake among groups was significantly different (p = 0.01). Food intake was 
significantly lower in the high-fat flaxseed oil (HF+FO) diet group compared to the low-fat 
control (LFC) (p = 0.04) and high-fat whole flaxseed (HF+WF) (p = 0.017) diet groups (Table 
2). No other significant differences in food intake were observed between groups.  
Table 2. Average Weekly Food Intake throughout 8 Weeks of Diet Treatment 
Diet Group Average Weekly Food Intake (g) 
High-Fat Control 25.23 ± 1.68 
High-Fat Defatted Flaxseed 21.68 ± 0.44 
Low-Fat Control 27.00 ± 1.13 
High-Fat Flaxseed Oil 20.25 ± 0.22 ce 
High-Fat Whole Flaxseed 27.53 ± 1.16 
1 Data are presented as mean ± standard error, p ˂0.05 
2 c Significantly decreased compared to low-fat control group (pair-fed to high-fat whole flaxseed 
diet group), e significantly decreased compared to high-fat whole flaxseed group (high-fat + 10% 
whole flaxseed)  
3All high-fat diets are 45% kcal from fat. Low-fat diet is 16% kcal from fat 
 Oxidation of Mouse Food 
 The food from HF+WF group was significantly less oxidized (p < 0.05) than the food 
from the high-fat control (HFC) group (Table 3). There were no other significant differences in 
oxidation between diet groups.  
Table 3.  Peroxide Value of Mouse Food 
Diet Group Peroxide Value (meq /kg fat) 
High-Fat Control 6.8 
High-Fat Defatted Flaxseed 3.2 
Low-Fat Control 3.0 
High-Fat Flaxseed Oil 3.2 
High-Fat Whole Flaxseed 1.9 a 
1 Data are presented as mean, p ˂0.05 
2 a Significantly lower compared to high-fat control 
3All high-fat diets are 45% kcal from fat. Low-fat diet is 16% kcal from fat 
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Effect of Diet on Weight Gain 
Prior to diet treatment there was a significant difference in body weight among diet 
groups (p = 0.0310). The high-fat defatted flaxseed (HF+DF) group weighted significantly less 
than the HF+WF group at the beginning of the study. After eight weeks of dietary treatment, 
weight gain was significantly different among groups (p < 0.001). HFC (p = 0.0087), HF+DF (p 
< 0.001), LFC (p < 0.001), and HF+FO (p < 0.001) diet groups had significantly less weight gain 
than the HF+WF group. The LFC group gained significantly less weight than the HF+DF (p < 
0.001), HF+FO (p = 0.0014), and the HFC (p < 0.001) groups. The HF+FO group gained 
significantly less than the HFC (p = 0.0079) (Table 4). 
Table 4. Pre-Weight, Post-Weight, and Weight Gain throughout 8 Weeks of Diet Treatment 
Diet Group Pre-Weight (g) Post-Weight (g) Weight Gain (g) 
High-Fat Control  19.88 ± 0.38 33.80 ± 0.98 13.92 ± 0.83 e 
High-Fat + Defatted Flaxseed  19.81 ± 0.47 e 31.55 ± 1.09 11.56 ± 0.69 e 
Low-Fat Control  19.61 ± 0.65 23.72 ± 0.72 4.33 ± 0.52 ebad 
High-Fat + Flaxseed Oil  19.93 ± 0.37 29.62 ± 0.62 9.54 ± 0.62 ea 
High-Fat + Whole Flaxseed  21.10 ± 0.31 39.27 ± 1.54 18.17 ± 1.34 
1Data are presented as mean ± standard error, p ˂0.05 
2 eSignificantly lower compared to high-fat whole flaxseed, bsignificantly lower compared to 
high-fat defatted flaxseed, asignificantly lower compared to the high-fat control, dsignificantly 
lower compared to high-fat flaxseed oil 
 3All high-fat diets are 45% kcal from fat. Low-fat diet is 16% kcal from fat   
Effect of Diet Treatment on Gene Expression 
Muscle Tissue 
 After eight weeks of dietary treatment, there were differences in gene expression among 
diet groups in the muscle tissue (p = 0.01). The expression of DNMT3b mRNA was reduced by 
21.26 fold (p = 0.0092), and PPAR-α mRNA was reduced by 17.47 fold (p = 0.03) in the 
HF+WF diet group compared to HFC group. The expression of DNMT3b mRNA was 
significantly reduced in the HF+WF group compared to HF+DF (p = 0.0392), LFC (p = 0.0386), 
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and HF+FO (p = 0.0144) groups. The expression of PPAR-α mRNA was significantly reduced in 
the HF+WF group compared to the HF+FO diet group (p= 0.0416) (Table 5). 
Table 5. Fold Change in Gene Expression in Muscle Tissue after 8 Weeks of Dietary Treatment 
Diet Group DNMT1 DNMT3a DNMT3b Leptin PPAR-α 
HF+DF  -2.26 ± 1.79 -2.03 ± 1.12 -4.47 ± 3.48 -4.15 ± 3.66 -4.07 ± 3.65 
LFC  -3.06 ± 1.93 -3.30 ± 2.11 -4.41 ± 3.03 -4.95 ± 3.75 -4.11 ± 3.33 
HF+FO  -0.84 ± 0.22 -1.26 ± 0.39 -1.30 ± 0.74 -1.20 ± 0.51 -0.88 ± 0.27 
HF+WF  -11.89 ± 10.22 -2.19 ± 1.43 -21.26 ± 19.11 
abcd -14.58 ± 13.63 -17.47 ± 15.55 ad 
1Data are presented as mean ± standard error, n=12; Samples were analyzed in duplicate and the 
average of the two samples was used for statistical analysis.  
2aSignificantly decreased compared to HFC, b significantly decreased compared to HF+DF, c 
significantly decreased compared to LFC, d significantly decreased compared to HF+FO, e 
significantly decreased compared to HF+WF, p <0.05. 
3Results were normalized to 18S rRNA mRNA levels and expressed as fold change. The fold 
change values were calculated as a relative change in comparison to the high-fat control 
(expression equals 1). 
4DNMT: DNA methyltransferase, PPAR-a: peroxisome proliferator-activated receptor alpha, 
HF: High-fat diet, DF: defatted flaxseed (6%), LFC: low-fat control, FO: flaxseed oil (4% 
flaxseed oil), WF: whole flaxseed (10%). 
5All high-fat diets are 45% kcal from fat. Low-fat diet is 16% kcal from fat.  
Adipose Tissue 
In the adipose tissue, there were also differences in gene expression among diet groups (p 
= 0.0001). The expression of DNMT1 mRNA was reduced by 10.32 fold in the HF+FO diet 
group compared to HFC group (p < 0.001). Leptin mRNA expression was reduced by 12.27 fold 
in the LFC diet (p < 0.001), 7.06 fold due to HF+FO diet (p = 0.0037), and 4.96 fold in the 
HF+WF diet (p = 0.0403), compared to HFC diet. Following treatment with the LFC and 
HF+FO diet, a significant change in gene expression was observed (p < 0.001 and p = 0.0002 
respectively). The expression of DNMT1 mRNA was significantly reduced in the HF+FO group 
compared to the LFC (p = 0.0010) and HF+WF (p = 0.0012) groups. Leptin mRNA expression 
was significantly reduced in the LFC group compared to the HF+DF (p < 0.001), HF+FO (p = 
0.0314), and HF+WF groups (p = 0.0026) (Table 6).   
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Table 6. Fold Change in Gene Expression in Adipose Tissue after 8 Weeks of Dietary Treatment 
Diet Group DNMT1 DNMT3a DNMT3b Leptin PPAR-α 
HF+DF  -5.76 ± 2.20 -2.75 ± 1.46 -1.35 ± 0.24 -2.01 ± 0.65 -0.88 ± 0.32 
LFC  -2.30 ± 0.68 -5.71 ± 1.45 -0.32 ± 0.11 -12.27 ± 3.94 abde -0.32 ± 0.10 
HF+FO  -10.32 ±6.06 ace -5.08 ± 2.45 -1.42 ± 0.64 -7.06 ± 2.63 ab -1.42 ± -.70 
HF+WF  -2.46 ±0.40 -0.99 ± 0.29 -0.87 ± 0.17 -4.96 ± 3.24 a -0.58 ± 0.11 
1Data are presented as mean ± standard error, n=12; Samples were analyzed in duplicate and the 
average of the two samples was used for statistical analysis.  
2aSignificantly decreased compared to HFC, b significantly decreased compared to HF+DF, c 
significantly decreased compared to LFC, d significantly decreased compared to HF+FO, e 
significantly decreased compared to HF+WF, p <0.05. 
3Results were normalized to 18sRNA mRNA levels and expressed as fold change. The fold 
change values were calculated as a relative change in comparison to the high-fat control 
(expression equals 1). 
4DNMT: DNA methyltransferase, PPAR-a: peroxisome proliferator-activated receptor alpha, 
HF: High-fat diet, DF: defatted flaxseed (6%), LFC: low-fat control, FO: flaxseed oil (4% 
flaxseed oil), WF: whole flaxseed (10%). 
5All high-fat diets are 45% kcal from fat. Low-fat diet is 16% kcal from fat. 
Correlation between DNMT, PPAR-α, and Leptin Expression 
In each diet group gene expression in both muscle and fat tissues was correlated to one 
another. Weight gains were also correlated to leptin and PPAR-α expression for each diet group 
and tissue. 
Muscle Tissue 
In the muscle tissue, there was a positive correlation between PPAR-α and leptin (p < 
0.001, r = 1.00), DNMT1 (p < 0.0001, r = 1.00), DNMT3a (p < 0.0001, r = 1.00) or DNMT3b 
mRNA expression (p < 0.0001, r = 0.99) in the HF+DF group. There was also a positive 
correlation between leptin and DNMT1 (p < 0.0001, r = 1.00), DNMT3a (p < 0.0001, r = 1.00), 
or D NMT3b mRNA expression (p < 0.0001, r = 0.99) in the HF+DF group. A positive 
correlation was also observed between DNMT1 and DNMT3a (p < 0.0001, r = 0.99) or 
DNMT3b (p < 0.0001, r = 0.99) and between DNMT3a and DNMT3b mRNA expression (p < 
0.0001, r = 0.97) (Table 7).  
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Table 7. Correlation between Gene Expression for HF+DF in Muscle Tissue 
  DNMT1 DNMT3a DNMT3b PPAR-α Leptin 
DNMT1 --- 0.99** 0.99** 1.00** 1.00** 
DNMT3a   --- 0.97** 1.00** 1.00** 
DNMT3b     --- 0.99** 0.99** 
PPAR-α       --- 1.00** 
Leptin         --- 
1Data are presented as Pearson correlation coefficients 
2*p<0.05 ** p<0.0001 
3HF+DF (high-fat diet [45% kcal from fat] + 6 defatted flaxseed) 
In the LFC group, there was a positive correlation between PPAR-α and leptin (p < 
0.0001, r = 1.00), DNMT1 (p < 0.0001, r = 0.99), DNMT3a (p < 0.0001, r = 0.99), or DNMT3b 
mRNA expression (p < 0.0001, r = 0.99). There was also a positive correlation between leptin 
and DNMT1 (p < 0.0001, r = 1.00), DNMT3a (p < 0.0001, r = 0.98), or DNMT3b mRNA 
expression (p < 0.0001, r = 1.00) in the LFC group. A positive correlation between DNMT1 and 
DNMT3a (p < 0.0001, r = 0.96), or DNMT3b (p < 0.001, r = 1.00) and between DNMT3a and 
DNMT3b mRNA expression (p < 0.0001, r = 0.97) was observed (Table 8).  
Table 8. Correlation between Gene Expression for LFC in Muscle Tissue 
  DNMT1 DNMT3a DNMT3b PPAR-α Leptin 
DNMT1 --- 0.96** 1.00** 0.99** 1.00** 
DNMT3a   --- 0.97** 0.99** 0.98** 
DNMT3b     --- 0.99** 1.00** 
PPAR-α       --- 1.00** 
Leptin         --- 
1Data are presented as Pearson correlation coefficients 
2*p<0.05 **p<0.0001 
3LFC (Low-fat control [16% kcal from fat], pair-fed to HF+FO group)  
In the HF+FO group, there was a positive correlation between PPAR-α and leptin (p < 
0.0001, r = 0.97), DNMT1 (p < 0.0001, r = 0.89), or DNMT3b mRNA expression (p < 0.0001, r 
= 0.94). There was a positive correlation between leptin and DNMT1 (p < 0.0001, r = 0.91) or 
DNMT3b mRNA expression (p < 0.0001, r = 0.98) in the HF+FO group. No significant 
correlation existed between DNMT1 and DNMT3a (p > 0.05, r = 0.08) or DNMT3a and 
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DNMT3b mRNA expression (p > 0.05, r = -0.06). However a significant positive correlation was 
observed between DNMT1 and DNMT3b mRNA expression (p < 0.001, r = 0.91) (Table 9).  
Table 9. Correlation between Gene Expression for HF+FO in Muscle Tissue 
  DNMT1 DNMT3a DNMT3b PPAR-α Leptin 
DNMT1 --- 0.08 0.91** 0.89** 0.91** 
DNMT3a   --- -0.06 0.24 0.07 
DNMT3b     --- 0.94** 0.98** 
PPAR-α       --- 0.97** 
Leptin         --- 
1Data are presented as Pearson correlation coefficients 
2*p<0.05 **p<0.0001 
3HF+DF (high-fat diet [45% kcal from fat] + 4% flaxseed oil) 
In the HF+WF diet group, PPAR-α mRNA expression was positively correlated with 
leptin (p < 0.001, r = 1.00), DNMT1 (p < 0.0001, r = 1.00), DNMT3a (p < 0.0001, r = 0.99), or 
DNMT3b mRNA expression (p < 0.0001, r = 1.00). There was also a positive correlation 
between leptin and DNMT1 (p < 0.0001, r = 1.00), DNMT3a (p < 0.0001, r = 0.99), or DNMT3b 
mRNA expression (p < 0.0001, r = 1.00) in the HF+WF group. A positive correlation between 
DNMT1 and DNMT3a (p < 0.0001, r = 0.99), or DNMT3b (p < 0.001, r = 1.00) and between 
DNMT3a and DNMT3b mRNA expression (p < 0.0001, r = 0.99) was observed (Table 10). 
Table 10. Correlation between Gene Expression for HF+WF in Muscle Tissue 
  DNMT1 DNMT3a DNMT3b PPAR-α Leptin 
DNMT1 --- 0.99** 1.00** 1.00*** 1.00** 
DNMT3a   --- 0.99** 0.99** 0.99** 
DNMT3b     --- 1.00** 1.00** 
PPAR-α       --- 1.00** 
Leptin         --- 
1Data are presented as Pearson correlation coefficients 
2*p<0.05 **p<0.0001 
3HF+DF (high-fat diet [45% kcal from fat] + 10% whole flaxseed) 
Adipose Tissue 
In the adipose tissue, there was a positive correlation between PPAR-α and leptin (p = 
0.0002, r = 0.88), DNMT1 (p < 0.0001, r = 0.90), or DNMT3a mRNA expression (p < 0.0001, r 
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= 0.93) in the HF+DF treatment group. There was also a positive correlation between leptin and 
DNMT1 (p < 0.0001, r = 0.92), or DNMT3a mRNA expression (p < 0.0001, r = 0.96). A 
significant correlation was not observed between leptin and DNMT3b mRNA expression (p > 
0.05, r = 0.25). A positive correlation between DNMT1 and DNMT3a (p < 0.0001, r = 0.97) was 
observed. No significant correlation was observed between DNMT1 and DNMT3b (p > 0.05, r = 
0.25) or DNMT3a and DNMT3b mRNA expression (p > 0.05, r = 0.22) (Table 11).  
Table 11. Correlation between Gene Expression for HF+DF in Adipose Tissue 
  DNMT1 DNMT3a DNMT3b PPAR-α Leptin 
DNMT1 --- 0.97** 0.25 0.90** 0.92** 
DNMT3a   --- 0.22 0.93** 0.96** 
DNMT3b     --- 0.5 0.25 
PPAR-α       --- 0.88* 
Leptin         --- 
1Data are presented as Pearson correlation coefficients 
2*p<0.05 **p<0.0001 
3HF+DF (high-fat diet [45% kcal from fat] + 6% defatted flaxseed) 
In the LFC group, there was a positive correlation between PPAR-α and leptin (p = 
0.0037, r = 0.77), DNMT1 (p = 0.0001, r = 0.89), or DNMT3b mRNA expression (p < 0.0001, r 
= 0.94) as well as between leptin and DNMT1 (p < 0.0001, r = 0.92), DNMT3a (p = 0.01, r = 
0.69), or DNMT3b mRNA expression (p < 0.05, r = 77). A positive correlation was observed 
between DNMT1 and DNMT3a (p < 0.05, r = 0.64) or DNMT3b (p < 0.05, r = 0.74). No 
significant correlation was observed between DNMT3a and DNMT3b mRNA expression (p > 
0.05, r = 0.31) (Table 12).  
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Table 12. Correlation between Gene Expression for LFC in Adipose Tissue 
  DNMT1 DNMT3a DNMT3b PPAR-α Leptin 
DNMT1 --- 0.64* 0.74* 0.89** 0.92** 
DNMT3a   --- 0.31 0.49 0.69* 
DNMT3b     --- 0.94** 0.61* 
PPAR-α       --- 0.77* 
Leptin         --- 
1Data are presented as Pearson correlation coefficients 
2*p<0.05 **p<0.0001 
3LFC (Low-fat control [16% kcal from fat], pair-fed to HF+FO group) 
 In the HF+FO treatment group there was a positive correlation between PPAR-α and 
DNMT1 (p < 0.0001, r = 0.99), DNMT3a (p = 0.0013, r = 0.81), or DNMT3b mRNA expression 
(p < 0.0001, r = 0.99). In the HF+FO group, there was also a positive correlation between leptin 
and DNMT1 (p = 0.02, r = 0.65), DNMT3a (p = 0.0004, r = 0.86), or DNMT3b (p = 0.02, r = 
0.58). A positive correlation was observed between DNMT1 and DNMT3a (p < 0.05, r = 0.84) 
or DNMT3b (p < 0.001, r = 0.98) and between DNMT3a and DNMT3b mRNA expression (p < 
0.05, r = 0.77) (Table 13). 
Table 13. Correlation between Gene Expression for HF+FO in Adipose Tissue 
  DNMT1 DNMT3a DNMT3b PPAR-α Leptin 
DNMT1 --- 0.84* 0.98** 0.99** 0.65* 
DNMT3a   --- 0.77* 0.81* 0.86* 
DNMT3b     --- 0.99** 0.58* 
PPAR-α       --- 0.65* 
Leptin         --- 
1Data are presented as Pearson correlation coefficients 
2*p<0.05 **p<0.0001 
3HF+DF (high-fat diet [45% kcal from fat] + 4% flaxseed oil) 
 In the HF+WF treatment group, there were no significant correlations observed between 
PPAR-α and DNMT1 (p > 0.05, r = 0.08), DNMT3a (p > 0.05, r = -0.46), or DNMT3b mRNA 
expression (p > 0.05, r = 0.49). No significant correlation was observed between leptin and 
DNMT1 (p > 0.05, r = -0.21), DNMT3a (p > 0.05, r = 0.09), or DNMT3b mRNA expression (p 
> 0.05, r = -0.36). No significant correlations were observed between DNMT1 and DNMT3a (p 
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> 0.05, r = 0.19) or DNMT3b mRNA expression (p > 0.05, r = 0.15). A significant negative 
correlation was observed between DNMT3a and DNMT3b mRNA expression (p < 0.05, r = -
0.64) (Table 14).   
Table 14. Correlation between Gene Expression for HF+WF in Adipose Tissue 
  DNMT1 DNMT3a DNMT3b PPAR-α Leptin 
DNMT1 --- 0.19 0.15 0.08 -0.21 
DNMT3a   --- -0.64* -0.46 0.09 
DNMT3b     --- 0.49 -0.36 
PPAR-α       --- -0.29 
Leptin         --- 
1Data are presented as Pearson correlation coefficients 
2*p<0.05 **p<0.0001 
3HF+DF (high-fat diet [45% kcal from fat] + 10% whole flaxseed) 
Correlation between Gene Expression and Body Weight 
Weight gain was correlated to leptin and PPAR-α expression for each diet group and 
tissue.  
In the muscle tissue, no correlation was observed between weight gain and PPAR-α or 
leptin expression for any of the diet groups (Table 15). 
Table 15. Correlation between PPAR-α mRNA or Leptin mRNA Expression and Weight Gain in 
Diet Treatment Groups in Muscle Tissue 
Diet Group PPAR-α Leptin 
HF+DF Weight Gain -0.27 -0.28 
LFC Weight Gain 0.41 0.41 
HF+FO Weight Gain -0.28 -0.26 
HF+WF Weight Gain 0.54 0.55 
1Data are presented as Pearson correlation coefficients 
2PPAR-a: peroxisome proliferator-activated receptor alpha, HF: High-fat diet, DF: defatted 
flaxseed (6%), LFC: low-fat control, FO: flaxseed oil (4% flaxseed oil), WF: whole flaxseed 
(10%). 
3All high-fat diets are 45% kcal from fat. Low-fat diet is 16% kcal from fat. 
There was also no correlation found in the adipose tissue (Table 16). 
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Table 16. Correlation between PPAR-α mRNA or Leptin mRNA Expression and Weight Gain in 
Diet Treatment Groups in Adipose Tissue 
Diet Group PPAR-α Leptin 
HF+DF Weight Gain -0.03 -0.1 
LFC Weight Gain -0.19 0.17 
HF+FO Weight Gain -0.38 -0.29 
HF+WF Weight Gain -0.23 -0.08 
1Data are presented as Pearson correlation coefficients 
2PPAR-a: peroxisome proliferator-activated receptor alpha, HF: High-fat diet, DF: defatted 
flaxseed (6%), LFC: low-fat control, FO: flaxseed oil (4% flaxseed oil), WF: whole flaxseed 
(10%). 
3All high-fat diets are 45% kcal from fat. Low-fat diet is 16% kcal from fat. 
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CHAPTER 5. DISCUSSION 
 Obesity has reached epidemic proportions in the United States with more than one-third 
(35.7%) of U.S. adults and 17% of children classified as obese (Centers for Disease Control and 
Prevention, 2012). Many interventions have been geared towards prevention of obesity. One 
avenue researchers have explored is epigenetic regulation through DNA methylation. DNA 
methylation can cause genes to be more highly expressed or silenced through access of 
transcription factors to genes (Shen et al., 2014). Compounds in the diet have been found to 
influence gene methylation. Cancer researchers have identified a compound found in green tea, 
EGCG, to cause decreased activity of the enzymes responsible for adding methyl groups to 
genes, DNA methyltransferases (DNMTs), leading to reactivation of tumor suppressor genes 
(Fang et al., 2003). Flaxseed contains both omega-3 fatty acid and an antioxidant lignan, 
secoisolariciresinol diglucoside (SDG), which has been found to improve obesity-related 
indicators (Baranowski et al., 2012; El-Shobaki, Mohamed, Abd-El-Azeem, & Hegazy, 2013) 
and prevent weight gain despite consumption of a high-fat diet (Park & Velasquez, 2012).  
Likely gene targets for studying prevention of obesity may include those with a known role in 
obesity. For example, leptin which regulates energy intake and expenditure (Meiera & Gressner, 
2004) and PPAR-α which regulates the activity of proteins involved in energy metabolism 
(Ferre, 2004) are two potential gene targets for this type of research. 
 In the present study, the effects of the health promoting compounds present in flaxseed 
on DNMT expression were investigated. As well as the relationships between DNMT and 
obesity-associated gene expression, and obesity-associated gene expression and body weight 
were determined. If negative correlations exist, further study would be warranted regarding 
flaxseed and prevention of weight gain through epigenetic regulation by DNA methylation.  
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Prior to dietary treatment, the HF+WF group had the highest body weight and was 
significantly greater than the HF+DF diet group. The HF+WF group also had the greatest 
average weekly food intake which was significantly greater than the HF+FO group.  The LFC 
group also had significantly greater food intake than the HF+FO. After eight weeks of dietary 
treatment, the HF+WF group gained significantly more weight than all other diet groups. The 
LFC group had significantly less weight gain among diet groups, which is to be expected due to 
low-fat content of the diet. The average percent difference in weight gain between the HF+WF 
and the LFC is 49.3%, likely indicating the development of DIO by the HF+WF group. 
Compared to the LFC group the HFC, HF+DF, and the HF+FO diet groups gained 35.1%, 
28.4%, and 22.1% more weight, respectively.  It is possible that the mice did not fully achieve 
DIO due to the short duration of the study, which lasted eight weeks. Lin et al. (2000) observed 
that there are three stages of developing DIO in C57BL/6J mice. They reported stage two occurs 
at eight weeks of feeding and is accompanied by reduced food intake, increased leptin secretion, 
and maintained leptin sensitivity. At 19 weeks, stage three, the mice had increased food intake 
and reduced leptin sensitivity (Lin, Thomas, Storlien, & Huang, 2000). In the current study, the 
mice may not have fully reached DIO and thus the final body weights may not reflect actual 
differences in weight due to dietary treatment.  
The HF+WF group gained significantly more weight than all other diet groups including the 
HFC group, which contradicts results from previous studies in which supplementation with n-3 
FA or SDG was protective against weight gain when consuming a high-fat diet (El-Shobaki, S. 
mohamed, Abd-El-Azeem, & Hegazy, 2013; Park & Valasquez, 2012; Tominaga et al., 2012). 
However, whole flaxseed also contains fiber and carbohydrates, which has shown to increase 
short chain fatty acid fermentation in the colon with possible effects on lipid metabolism and 
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ultimately weight regulation (Conterno, Fava, Viola, & Tuoh, 2011). Although current research 
is inconclusive as to the exact relationship between gut environment and weight regulation, it is 
possible that a similar mechanism is responsible for the significant weight gain observed in the 
HF+WF group. This explanation would not be fitting for the HF+DF diet which has similar fiber 
and carbohydrate content because these mice gained less weight than the HF+WF group. Both 
the HF+DF and the HF+FO group gained significantly less weight than the HF+WF, which may 
indicate the ability of each component of flaxseed, the n-3 FA and the SDG, to protect against 
weight gain separately rather than in combination.  
Additionally, the HF+FO group also consumed significantly less food than the HF+WF and 
LFC group, which raises the possibility that a high-fat diet accompanied by flaxseed oil intake 
may be protective against weight gain through regulation of food intake. Similar results have 
been seen in a DIO mice model where mice were fed a high-fat diet that was either n-3 FA rich 
or n-3 FA deficient. The mice that were in the n-3 FA containing group consumed significantly 
less food than the n-3 FA deficient group (Fan, Liu, Shen, Deckellbaum, & Qi, 2011).  
Another possible explanation as to why the HF+FO group consumed significantly less food 
may be due to oxidation of the foods, as rancid fats cause foods to have an undesirable aroma 
and taste. To minimize the possibility of this happening fresh food was provided daily. We tested 
the peroxide value on samples of the food from each group and found that the HF+FO food was 
not significantly more oxidized than any of the other groups. Surprisingly, the HFC was the most 
oxidized, which was only significant compared to the HF+WF, and was not reflected in food 
intake.   
In contrast, although the HF+DF gained significantly less weight than the HF+WF group, 
they did not consume significantly less food. This provides evidence that supplementation of 
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defatted flaxseed may have prevented weight gain by a mechanism other than through regulating 
intake, such as epigenetic regulation. Similar results have been found by Boque et al. (2013), 
when feeding rats a high-fat diet supplemented with apple polyphenols, which possess 
antioxidant properties. Supplementation with apple polyphenols in combination with a high-fat 
sucrose diet, prevented weight gain without decreased food intake. The authors speculated that 
this compound regulates gene expression through epigenetic regulation by DNA methylation 
(Boque et al., 2013). Due to the HF+DF group gaining significantly less weight than the HF+WF 
group without significantly less food intake, it is possible that SDG, with its antioxidant 
properties, is capable of preventing weight gain through epigenetic regulation as has been 
demonstrated with other antioxidants.  
Unexpectedly, DNMT3b was significantly lower in the muscle tissue of the HF+WF group, 
which gained significantly more weight than all other groups. We would expect that DNMT3b, 
as well as DNMT1 and DNMT3a would negatively correlate with obesity-associated gene 
expression of PPAR-α or leptin because, in theory, reduced DNMT expression would indicate 
decreased methylation of genes allowing for increased gene expression. However, all significant 
correlations observed between DNMT expression and PPAR-α or leptin expression were positive 
in all treatment groups of both muscle and adipose tissue. A link between promoter methylation 
and gene expression has been well established. Fujiki et al. (2009) demonstrated that PPAR-γ 
expression is reduced when its promoter is hypermethylated, and when treated with a DNA 
methylation inhibitor its expression is increased in a dose dependent manner (Fujiki, Kano, 
Shiota, & Murata, 2009). In contrast, Yang et al. (2014) reported a positive correlation between 
DNA methylation and gene expression when the gene was methylated on the body region rather 
than the promoter region (Yang et al., 2014). Boque et al. (2013) and Ngo et al. (1996) also 
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observed a positive correlation between DNA methylation and gene expression. They concluded 
that the positive correlation may be due to DNA methylation occurring on negative regulatory 
elements, which could increase transcription on the gene (Boque et al., 2013; Ngo, Gourdji, & 
Laverriere, 1996). In the present study, analysis of DNA methylation was not performed. It is 
possible that PPAR-α and leptin were methylated on the body region rather than the promoter 
region resulting in a positive correlation. However, further research is needed to identify the 
relationship between DNA methylation and gene expression.   
Reduced expression of DNMT1 in the HF+FO group was observed in the adipose tissue. This 
group gained significantly less weight than the HFC and HF+WF groups, but a positive 
correlation was also observed between DNMT1 and PPAR-α expression. Again, this could 
potentially be due to the previously mentioned mechanism. 
Kamei et al., (2009) studied a model of transgenic mice overexpressing DNMT3a and found 
that DNMT3a expression was increased in the adipose tissue but not the skeletal muscle or liver 
tissue (Kamei et al., 2009). This may explain why DNMT3a expression was not increased in 
muscle tissue. However, DNMT3a was also not more highly expressed in the adipose tissue of 
any diet group. Although Kamei et al. (2009) concluded DNMT3a may play a role in obese 
adipose tissue, there were several differences in study design that may account for the 
differences observed in DNMT3a expression. Most notably was the intentional overexpression of 
DNMT3a (Kamei et al., 2009). Further research is needed to determine the role of DNMT3a in 
the tissues of obese mice.  
It is also possible that the compounds present in flaxseed are not capable of regulating 
DNMT expression. Compounds such as epigallocatechin gallate (EGCG) have been found to 
demethylate genes to increase expression by decreasing DNMT1 expression, while others such 
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as curcumin have not exhibited this effect (Mirza et al., 2013). An alternative explanation for the 
flaxseed being unable to regulate obesity-associated gene expression may be due to their 
inability to activate DNMTs, with the exception of the HF+FO group in which DNMT1 was 
significantly reduced compared to HFC group. If DNMTs were activated they may be able to add 
methyl groups to genes, therefore regulating gene expression. It has been reported that 
compounds such as EGCG interact with DNMT1 at its catalytic center to initiate activity. 
Specifically, it has been proposed that these compounds contain a gallic/pyrogallic acid moiety 
that enables them to initiate DNMT activity (Li & Tollefsbol, 2010). The possibility exists that 
the compounds present in flaxseed are not capable of interacting with DNMT catalytic site, and 
thus not capable of epigenetic modification by DNA methylation. However, DNMT activity has 
not been measured in this study so this relationship remains inconclusive. 
As expected, in the muscle tissue, PPAR-α mRNA expression was significantly reduced in 
the HF+WF group, which gained the most weight, although decreased compared to all groups, 
this was only significant in comparison with the HFC and HF+FO groups. This supports 
previous reports that PPAR-α increases energy expenditure (Ferre, 2004), and is decreased with 
increased weight gain (Guerre-Millo et al., 2000). This same result was not observed in the 
adipose tissue, but it could be due to tissue dependent expression of PPAR-α. Peroxisome 
proliferator-activated receptor alpha is more highly expressed in the liver and muscle tissues 
compared to adipose tissue (Ferre, 2004), which may have prevented a significant difference in 
expression in the adipose tissue. 
Significantly less leptin mRNA expression occurred in the adipose tissue of the LFC group 
compared to all other groups. This was expected because the LFC group had the least weight 
gain; therefore, leptin expression is reflective of fat stores rather than ability to regulate weight in 
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DIO due to development of leptin resistance, which has been previously reported (Boque et al., 
2013; Moraes et al., 2003). Both the HF+FO and the HF+WF groups had significantly less  
leptin mRNA expression in the adipose tissue compared to the HFC group. The HF+FO group 
gained the least weight of all three of the high-fat groups; however, this was only significant in 
comparison to the HFC or HF+WF groups. This is consistent with previous reports that 
supplementation with n-3 FA decreases leptin mRNA expression in adipose tissue. Fan et al. 
(2011) fed mice a low-fat control diet or one of four high-fat diets. The high-fat diets were 
supplemented with soybean oil, fish oil, a mixture of soybean and fish oil (1:1 ratio), which 
contained n-3 FA, or sunflower oil which was n-3 FA deficient. Body weight, food intake, and 
leptin expression were lower  in all three of the n-3 FA diets compared to the n-3 FA deficient 
diet. Plasma leptin levels were decreased in all three n-3 FA diets, but this was only significant 
between the fish oil n-3 FA diet and the n-3 FA deficient diet (Fan et al., 2011). Together, the 
reduced leptin mRNA expression and decreased plasma leptin indicate maintained leptin 
sensitivity, which may help explain why the HF+FO diet group had least weight gain and 
reduced leptin expression compared to HFC. While not significant, Fan et al. (2011) also 
observed a decreased methylation in many of the leptin promoter CpG sites in the low-fat control 
groups compared to the high-fat diet groups. A reduced methylation level was also observed in 
the high-fat n-3 FA containing diets compared to the n-3 FA deficient groups, although also not 
statistically significant (Fan et al., 2011). The decrease in promoter methylation observed in both 
the high-fat n-3 FA containing diet and the low-fat control diet suggest a possible relationship 
between DNA methylation, weight regulation, and n-3 FA supplementation. 
In contrast, the HF+WF group gained the most weight of all three high-fat diets. The reduced 
leptin mRNA expression and highest weight gain is counterintuitive. This may be explained by 
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the short duration of the feeding intervention, in which there was not sufficient time to allow 
body weight to reflect leptin action. This may be overshadowed by the increased intake 
associated with fiber and carbohydrate content of whole flaxseed as mentioned earlier, which 
resulted in weight gain not observed in the HF+FO group. Further research is needed to 
determine the role of flaxseed in leptin and weight regulation. Leptin mRNA expression was not 
significantly influenced in the muscle tissue which may be due to leptin being primarily secreted 
in the adipose tissue (Meiera & Gressner, 2004).  
Leptin expression, through supplementation of n-3 FA, may not be solely regulated by DNA 
methylation, but may instead be regulated by other epigenetic mechanisms. When mice were fed 
a high-fat diet and supplemented with n-3 FA from fish oil, plasma leptin concentration and 
leptin expression in adipose tissue was significantly lower compared to the high-fat diet group 
without n-3 FA supplementation. Addition of n-3 FA did not affect methylation of CpG sites of 
the leptin promoter. However, it did reduce DNMT1 and MBD2 binding at promoter, but 
DNMT3a and DNMT3b were not affected. Also in the low-fat control group, there was a 
negative correlation between leptin promoter methylation and leptin expression. However, it was 
reversed in the mice fed a high-fat diet without n-3 FA supplementation, showing a positive 
correlation between leptin promoter methylation and leptin expression. The authors concluded 
the positive correlation observed in the obese mice may indicate an altered regulation of leptin 
expression in the obese state. Although the mechanism behind this is unknown, it is a possible 
explanation as to why leptin is increased in the obese state (Shen et al., 2014). Further 
investigation of this mechanism may help determine how to epigenetically target leptin in 
regards to weight regulation. Though other studies indicate that leptin may be regulated by DNA 
methylation of its promoter regions (Milagro et al., 2009), which is also possible through 
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supplementation of compounds in the diet (Boque et al., 2013); however, it is unclear if n-3 FA 
are capable of regulating leptin expression through DNA methylation. 
Unexpectedly, in the current study no correlation was observed between weight gain and 
PPAR-α or leptin expression in any of the diet groups. This may also be due to the short length 
of the study in which weight did not yet reflect gene expression. It is possible that if feeding had 
continued to 19 weeks, as reported previously to be the final stage of DIO development (Lin et 
al., 2000), weight may have reflected gene expression as expected. The lack of correlation 
between leptin expression and bodyweight may also be explained by the development of leptin 
resistance. Lin et al. (2000) observed plasma leptin to be increased by 223% at eight weeks 
during DIO, which may explain leptin resistance (Lin et al., 2000). However, in this study serum 
leptin was not measured; therefore, development of leptin resistance as evidenced by increased 
serum leptin cannot be determined. Peroxisome proliferator-activated receptor alpha expression 
may not have been correlated with body weight due to it not being activated, as PPAR-α activity 
is regulated by ligands produced in the body (Ferre, 2004). However, PPAR-α activity was not 
measured in this study, so the relationship between body weight and PPAR-α expression also 
remains elusive.  
Limitations to this study include the short duration of the feeding intervention which may 
not have allowed mice to fully develop DIO (Lin et al., 2000), as mentioned above. This study 
was performed using an animal model and may not be generalizable to humans in regards to 
regulatory mechanisms involved in obesity and obesity reduction, which are different between 
species. This experiment was carried out in a controlled setting and may not accurately represent 
the events occurring in a natural environment. Another limitation is not measuring serum leptin. 
If serum leptin would have been measured, it could have been identified if leptin resistance was 
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developed as increased plasma leptin is indicative of leptin resistance. This could potentially 
explain why the HF+WF and the HF+FO groups had significantly less  leptin expression while 
simultaneously having significant differences in weight gain. The activity of PPAR-α determined 
by its ability to induce expression of genes involved in lipid catabolism, may have provided 
insight as to whether PPAR-α expression accurately reflected its function in obesity (Ferre, 
2004). Measurement of DNMT activity, determined by the ability of the health-promoting 
compounds in flaxseed to initiate DNMT activity by interacting with its catalytic center, may 
have provided further insight into the role of diet in DNMT activation (Li & Tollefsbol, 2010). 
Another limitation to methodology is not including western blotting to confirm proteins 
identified by RT-qPCR. The methylation profile of leptin and PPAR-α was not measured in this 
study, limiting data to correlational reports between DNMT and leptin or PPAR-α expression.  
Future research should focus on determining the ability of flaxseed to affect the 
concentration and/or activity of DNMTs as well as the mechanism responsible. Furthermore, 
studies should aim to identify if leptin and PPAR-α are epigenetically regulated, specifically by 
DNA methylation. As discussed previously, we did not look at the methylation profile of each 
gene and were unable to determine the relationship between gene methylation and its resulting 
expression. In future studies, plasma leptin should be considered to differentiate between 
increased leptin action and increased leptin expression resulting in leptin resistance.  
In conclusion, the results indicate that supplementation with flaxseed affected selected gene 
expression. However, this was a preliminary study to observe if there was a possible relationship 
between DNMT and obesity-associated gene expression as a factor of flaxseed supplementation. 
Further research is needed to identify the specific mechanisms regulating leptin or PPAR-α 
expression during DIO development.  
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